证券之星消息，根据天眼查APP于3月11日公布的信息整理，博瑞生物医药泰兴市有限公司A轮融资，融资额未披露，参与投资的机构包括中国信达，浙江产投。博瑞生物医药泰兴市有限公司经营范围包括生物原料药(纽莫康定、阿卡波糖、万古霉素、埃坡霉素、达托霉素、腺苷蛋氨酸、子囊霉素、西罗莫司、非达米星、卡泊芬净、米卡芬净、阿尼芬净、吡美莫司)等。数据来源：天眼查APP为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。
证券之星消息，根据天眼查APP于3月11日公布的信息整理，博瑞生物医药泰兴市有限公司A轮融资，融资额未披露，参与投资的机构包括中国信达，浙江产投。博瑞生物医药泰兴市有限公司经营范围包括生物原料药(纽莫康定、阿卡波糖、万古霉素、埃坡霉素、达托霉素、腺苷蛋氨酸、子囊霉素、西罗莫司、非达米星、卡泊芬净、米卡芬净、阿尼芬净、吡美莫司)等。数据来源：天眼查APP为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.